| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.092 | 0.04 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.04 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.04 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.04 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.094 | 0.05 |